HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolic instability of Escherichia coli cyclopropane fatty acid synthase is due to RpoH-dependent proteolysis.

Abstract
Cyclopropane fatty acids (CFAs) are generally synthesized as bacterial cultures enter stationary phase. In Escherichia coli, the onset of CFA synthesis results from increased transcription of cfa, the gene encoding CFA synthase. However, the increased level of CFA synthase activity is transient; the activity quickly declines to the basal level. We report that the loss of CFA activity is due to proteolytic degradation dependent on expression of the heat shock regulon. CFA synthase degradation is unaffected by mutations in the lon, clpP, and groEL genes or by depletion of the intracellular ATP pools. It seems likely that CFA synthase is the target of an unidentified energy-independent heat shock regulon protease. This seems to be the first example of heat shock-dependent degradation of a normal biosynthetic enzyme.
AuthorsY Y Chang, J Eichel, J E Cronan Jr
JournalJournal of bacteriology (J Bacteriol) Vol. 182 Issue 15 Pg. 4288-94 (Aug 2000) ISSN: 0021-9193 [Print] United States
PMID10894739 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Chaperonin 60
  • Heat-Shock Proteins
  • Sigma Factor
  • Transcription Factors
  • heat-shock sigma factor 32
  • Methyltransferases
  • cyclopropane synthetase
  • Serine Endopeptidases
  • Endopeptidase Clp
  • Adenosine Triphosphatases
Topics
  • Adenosine Triphosphatases (genetics)
  • Chaperonin 60 (genetics)
  • Electrophoresis, Polyacrylamide Gel
  • Endopeptidase Clp
  • Enzyme Stability
  • Escherichia coli (enzymology)
  • Heat-Shock Proteins (metabolism)
  • Methyltransferases (metabolism)
  • Mutagenesis, Site-Directed
  • Regulon (genetics)
  • Serine Endopeptidases (genetics)
  • Sigma Factor
  • Time Factors
  • Transcription Factors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: